Trials / Sponsors / IFOM ETS - The AIRC Institute of Molecular Oncology
IFOM ETS - The AIRC Institute of Molecular Oncology
Academic / Other · 7 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | The Sagittarius Trial Colon Cancer Stage II, Colon Cancer Stage III | Phase 3 | 2024-10-22 |
| Recruiting | Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Primi Triple Negative Breast Cancer Metastatic | Phase 2 | 2022-12-15 |
| Recruiting | A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ) Colorectal Cancer | — | 2020-10-28 |
| Recruiting | A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer Breast Cancer | — | 2020-07-16 |
| Unknown | Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PE Colon Cancer | Phase 2 | 2020-06-16 |
| Recruiting | ALFAOMEGA Master Observational Trial Colorectal Cancer | — | 2019-10-15 |
| Completed | Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation Colorectal Neoplasms, Microsatellite Instability | Phase 2 | 2019-01-23 |